甲状腺微小乳头状癌诊治进展

doi:10.11904/j.issn.1002-3070.2017.01.013

实用肿瘤学杂志 ›› 2017, Vol. 31 ›› Issue (1): 61-64.doi: 10.11904/j.issn.1002-3070.2017.01.013

甲状腺微小乳头状癌诊治进展

林前煌, 徐慧综述, 郇金亮校审

江苏大学附属上海第八医院普外科(上海 200235)

收稿日期:2016-07-10 出版日期:2017-02-28 发布日期:2017-02-20
通讯作者: 郇金亮,E-mail:huanjl2000@126.com
作者简介:林前煌,男,(1987-),硕士,住院医师,从事甲状腺、乳腺疾病的诊断及外科治疗方面的研究

Research progress in diagnosis and treatment of papillary thyroid microcarcinoma

LIN Qianhuang, XU Hui, HUAN Jinliang

Department of General Surgery,Shanghai The Eighth Hospital of Jiangsu University,Shanghai 200235,China

Received:2016-07-10 Online:2017-02-28 Published:2017-02-20

摘要/Abstract

摘要： 甲状腺癌属于人体内分泌系统最常见的恶性肿瘤,是头颈、甲乳外科常见病之一,其发病率连年显著递增。随着超声和细针穿刺细胞学检查的开展,以及基因检测技术的辅助检查,早期诊断甲状腺微小乳头状癌的检出率越来越高。相比较于传统的外科手术,彰显微创美容的优势,内镜及超声定位下经皮消融术等新的手术方式逐步应用于临床治疗。结合新指南,本文将对甲状腺微小乳头状癌的诊治进展进行详细综述。

关键词: 甲状腺肿瘤, 微小乳头状癌, 诊断, 治疗, 指南

Abstract: Thyroid cancer is one of the most common malignant tumors in the human endocrine system.It is one of the common diseases in head and neck,thyroid and breast surgery.Its incidence rate is increasing year by year.With the development of ultrasonography and fine needle aspiration biopsy,as well as the auxiliary examination of gene detection technology,the detective rate of early diagnosis of papillary thyroid microcarcinoma(PTMC)is getting higher and higher.Compared with conventional surgery,highlighting the advantages of minimally invasive surgery,endoscopic and ultrasound guided percutaneous ablation and other new surgical Methods are gradually applied in clinical treatment.Combined with the new guideline,the present paper reviews the progress in the diagnosis and treatment of papillary thyroid microcarcinoma.

Key words: Thyroid tumor, Papillary microcarcinoma, Diagnosis, Treatment, Guideline

中图分类号:

R736.1

林前煌, 徐慧综述, 郇金亮校审. 甲状腺微小乳头状癌诊治进展[J]. 实用肿瘤学杂志, 2017, 31(1): 61-64.

LIN Qianhuang, XU Hui, HUAN Jinliang. Research progress in diagnosis and treatment of papillary thyroid microcarcinoma[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 61-64.

参考文献

1 WHO/IARC.World cancer report 2014[M].Lyon:IARC Press,2014:738-750.
2 Zhang L,Wei WJ,Ji QH,et al.Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma:a study of 1066 patients[J].J Clin Endocrinol Metab,2012,97(4):1250-1257.
3 Sakorafas GH,Giotakis J,Stafyla V.Papillary thyroid microcarcinoma:a surgical perspective[J].Cancer Treat Rev,2005,31(6):423-438.
4 高慧霞.超声诊断甲状腺微小乳头状癌的价值与临床病理对照[J].中国继续医学教育,2015,7(20):69-70.
5 Moon WJ,Baek JH,Jung SL,et al.Ultrasonography and the ultrasound-based management of thyroid nodules:consensus statement and recommendations[J].Korean J Radiol,2011,12(1):1-14.
6 Md HB,Alexander EK,Bible KC,et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133.
7 Ferraz C,Eszlinger M,Paschke R.Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules[J].J Clin Endocrinol Metab,2011,96(7):2016-2026.
8 Adeniran AJ,Theoharis C,Hui P,et al.Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation:a prospective study[J].Thyroid,2011,21(7):717-723.
9 Melo M,Da RA,Vinagre J,et al.TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas[J].J Clin Endocrinol Metab,2014,99(5):E754-765.
10 Xing M,Liu R,Liu X,et al.BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence[J].J Clin Oncol,2014,32(25):2718-2726.
11 Liu X,Qu S,Liu R,et al.TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer[J].J Clin Endocrinol Metab,2014,99(6):1130-1136.
12 中华医学会内分泌学分会,中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272.
13 Li F,Chen G,Sheng C,et al.BRAF V600E mutation in papillary thyroid microcarcinoma:a meta-analysis[J].Endocr Relat Cancer,2015,22(2):159-168.
14 Zhou YL,Zhang W,Gao EL,et al.Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma[J].Asian Pac J Cancer Prev,2012,13(4):1267-1272.
15 Ito Y,Miyauchia A,Kihara M,et al.Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J].Thyroid,2014,24(1):27-34.
16 Zheng X,Wei S,Han Y,et al.Papillary microcarcinoma of the thyroid:clinical characteristics and BRAF(V600E)mutational status of 977 cases[J].Ann Surg Oncol,2013,20(7):2266-2273.
17 Valcavi R,Piana S,Bortolan GS,et al.Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma:a feasibility study on three cases with pathological and immunohistochemical evaluation[J].Thyroid,2013,23(12):1578-1582.
18 刘晓岭,黄靖,孙德胜,等.超声引导下射频消融治疗甲状腺微小乳头状癌的临床体会[J].黑龙江医学,2015,39(1):69-70.
19 Creach KM,Siegel BA,Nussenbaum B,et al.Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma[J].ISRN Endocrinol,2012,2012:8163-8186.
20 Sabaretnam M,Ramakant,Abraham DT,et al.Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma[J].Clinical Endocrinology,2013,78(4):444-445.
21 Lang HH,Wong IOL,Kai PW,et al.Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy[J].Surgery,2012,151(6):844-850.

[1]	侯玉雪,李晓莉. Wnt7a与恶性肿瘤的关系及研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 271-275.
[2]	朱琳,张春霞. 纳米载药系统靶向肿瘤干细胞的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 276-279.
[3]	李珊,赵春波,乔文波. 术中放疗在胰腺癌中的应用进展[J]. 实用肿瘤学杂志, 2019, 33(3): 280-283.
[4]	孙江宏, 郝明珠, 姜丹, 国飞, 李晓梅. 乳腺炎、良性增生及乳腺癌FFDM鉴别诊断思路[J]. 实用肿瘤学杂志, 2019, 33(2): 139-141.
[5]	方琳, 刘超, 张纯慧, 张艳桥. 转移性结直肠癌维持治疗的研究现状与治疗策略[J]. 实用肿瘤学杂志, 2019, 33(2): 173-178.
[6]	佟广海, 田洋, 吴华星. 脂质组学在结直肠癌研究中的应用[J]. 实用肿瘤学杂志, 2019, 33(2): 179-192.
[7]	丁界先, 张津, 陈永刚, 王兴文综述, 王栓科审校. Wnt信号通路与肿瘤发生的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 73-77.
[8]	邢志超综述, 麦威审校. 脂肪肉瘤潜在作用靶点的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 82-86.
[9]	张攀, 张迪综述, 戴晓波审校. 复发鼻咽癌再程放射治疗的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 92-96.
[10]	田洋, 吴华星. 超细鼻胃镜在消化道狭窄性疾病中的临床应用[J]. 实用肿瘤学杂志, 2018, 32(6): 550-554.
[11]	王鹏, 周海涛, 梁建伟, 周志祥. 肠系膜纤维瘤病误诊为早期直肠癌根治术后复发1例报道及文献复习[J]. 实用肿瘤学杂志, 2018, 32(5): 442-444.
[12]	李悦, 徐可, 韩增祥, 孙敏, 樊国华综述, 张勇审校. 结肠癌中肿瘤相关巨噬细胞的作用及靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 450-454.
[13]	王元综述, 孙轶华审校. β-连环蛋白在软组织肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 455-459.
[14]	方振剑, 吴正琮, 郑宏宗, 敖日影, 赖国祥. CT增强对不同大小密度孤立性肺结节的诊断价值[J]. 实用肿瘤学杂志, 2018, 32(4): 333-336.
[15]	李宏伟, 蒋小凤, 陈松, 别一非, 杜勇. 头部巨大瘢痕鳞状细胞癌伴颅骨、硬脑膜侵犯一例[J]. 实用肿瘤学杂志, 2018, 32(4): 337-339.

甲状腺微小乳头状癌诊治进展

Research progress in diagnosis and treatment of papillary thyroid microcarcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价